Marshall Wace, LLP Evelo Biosciences, Inc. Transaction History

Marshall Wace, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.07 - $12.0 $235,558 - $465,684	-38,807 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.79 - $13.9 $161,568 - $330,750	-23,795 Reduced 38.01%	38,807 $273,000
Q2 2021 Aug 13, 2021	SELL	$9.43 - $16.6 $823,465 - $1.45 Million	-87,324 Reduced 58.24%	62,602 $861,000
Q1 2021 May 17, 2021	BUY	$9.71 - $18.6 $1.05 Million - $2.02 Million	108,551 Added 262.36%	149,926 $1.6 Million
Q4 2020 Feb 16, 2021	BUY	$3.91 - $12.28 $161,776 - $508,085	41,375 New	41,375 $500,000
Q4 2019 Feb 14, 2020	SELL	$3.81 - $7.45 $23,614 - $46,175	-6,198 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$5.45 - $8.8 $33,779 - $54,542	6,198 New	6,198 $38,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.